![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 39/00 | (2006.01) |
A61K 48/00 | (2013.01) | ||
C07K 14/725 | (2006.01) | ||
C07K 14/7051 | (2013.01) | ||
A61P 35/00 | (2006.01) | ||
C07K 14/70517 | (2013.01) | ||
A61K 31/519 | (2006.01) | ||
C07K 16/303 | (2013.01) | ||
A61K 31/664 | (2006.01) | ||
C07K2319/02 | (2013.01) | ||
A61K 31/7048 | (2006.01) | ||
C07K2319/03 | (2013.01) | ||
A61K 38/20 | (2006.01) | ||
A61P 35/00 | (2018.01) | ||
C07K2317/24 | (2013.01) | ||
C07K 14/705 | (2006.01) | ||
A61K 31/7076 | (2006.01) | ||
C07K2317/622 | (2013.01) | ||
C07K2319/33 | (2013.01) | ||
C07K 16/30 | (2006.01) | ||
C12N2740/16043 | (2013.01) | ||
A01K2207/12 | (2013.01) | ||
A01K2227/105 | (2013.01) | ||
A61K 35/17 | (2013.01) | ||
A61K 31/519 | (2013.01) | ||
A61K 31/664 | (2013.01) | ||
A61K 31/7048 | (2013.01) | ||
A61K 31/7076 | (2013.01) | ||
A61K 38/2013 | (2013.01) | ||
A61K 38/202 | (2013.01) | ||
A61K 38/204 | (2013.01) | ||
A61K 38/2073 | (2013.01) | ||
A61K 39/001174 | (2018.08) | ||
A61K2039/5158 | (2013.01) | ||
A61K2039/5156 | (2013.01) |
(11) | Number of the document | 3445407 |
(13) | Kind of document | T |
(96) | European patent application number | 17833264.9 |
Date of filing the European patent application | 2017-04-21 | |
(97) | Date of publication of the European application | 2019-02-27 |
(45) | Date of publication and mention of the grant of the patent | 2022-12-14 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/CN2017/081446 |
Date | 2017-04-21 |
(87) | Number | WO 2018/018958 |
Date | 2018-02-01 |
(30) | Number | Date | Country code |
201610256568 | 2016-04-22 | CN |
(72) |
LI, Zonghai , CN
GAO, Huiping , CN
WANG, Peng , CN
JIANG, Hua , CN
WANG, Huamao , CN
|
(73) |
CRAGE medical Co., Limited ,
RM12, 20/F, Ho King Comm CTR,
2-16 FaYuen ST,
Mongkok Kowloon,, Hong Kong,
CN
|
(54) | COMPOSITIONS AND METHODS OF CELLULAR IMMUNOTHERAPY |
COMPOSITIONS AND METHODS OF CELLULAR IMMUNOTHERAPY |